Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct:220:173462.
doi: 10.1016/j.pbb.2022.173462. Epub 2022 Sep 7.

Effects of environmental manipulations on cocaine-vs-social choice in male and female rats

Affiliations

Effects of environmental manipulations on cocaine-vs-social choice in male and female rats

Madison M Marcus et al. Pharmacol Biochem Behav. 2022 Oct.

Abstract

Cocaine use disorder occurs in an environment where cocaine and other nondrug commodities are concurrently available. Preclinical drug-vs-nondrug choice procedures are one simplified method of modeling this complex clinical environment. The present study established a discrete-trial cocaine-vs-social interaction choice procedure in male and female rats and determined sensitivity of choice behavior to manipulations of reinforcer magnitude and non-contingent "sample" reinforcer presentation. Rats could make up to nine discrete choices between an intravenous cocaine infusion (0.1-1.0 mg/kg/inf) and social interaction with a same-sex social "Partner" rat. Cocaine infusions were available under a progressive-ratio (PR) schedule of reinforcement, and social interaction was available under a fixed-ratio (FR) 3 schedule. Social interaction was chosen over no or small cocaine doses (saline, 0.01 mg/kg/inf) and behavior was reallocated away from social and towards cocaine at larger cocaine doses (1.0 mg/kg/inf). Manipulating social interaction time as one method to alter social reinforcer magnitude did not significantly alter cocaine-vs-social choice. Removing the non-contingent reinforcer presentations before the discrete choice trials also failed to affect cocaine-vs-social choice, suggesting the time interval was sufficient to minimize any potential influence of the non-contingent cocaine infusions on subsequent choice behavior. Overall, the present results were consistent with previous drug-vs-social choice studies and extend our knowledge of environmental factors impacting drug-vs-social choice. Future studies determining the pharmacological sensitivity of cocaine-vs-social choice will be important in expanding the preclinical utility of these procedures for candidate medication drug development.

Keywords: Addiction; Choice; Cocaine; Progressive ratio; Self-administration; Social interaction.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest All authors report no conflicts of interest.

Figures

Figure 1.
Figure 1.
Effect of cocaine dose on cocaine-vs.-social interaction choice. Top panels: (A) percent cocaine choice as a function of cocaine dose. (B) trials completed for cocaine (PR 3, 6, 10, 18, 32, 56, 100, 180, 320), completed for social interaction (FR3), or omitted as a function of cocaine dose. All points represent the mean ± SEM for the final 2 days of testing. Filled points denote statistical significance (p < 0.05) relative to saline; symbols represent significant (p < 0.05) comparisons within a dose: *difference from the other reinforcer and omitted trials; #difference from omitted trials only. Bottom panels: Individual subject behavioral allocation on the final day of testing between cocaine (red), social interaction (black), or omitted trials (white) when the alternative to social interaction was 0.1 mg/kg/inf cocaine (C) or 1.0 mg/kg/inf cocaine (D). Each row corresponds to a single subject, and each column corresponds to a discrete choice trial. Results depicted are representative of one testing day. n = 5 (2M/3F) for saline, n = 6 (2M/4F) for 0.10 mg/kg/inf cocaine, n = 5 (2M/3F) for 0.32 mg/kg/inf, and n = 7 (3M/4F) for 1.0 mg/kg/inf cocaine.
Figure 2.
Figure 2.
Cocaine-vs-social interaction choice across testing days. Abscissae: testing day. Ordinates: number of trials completed for cocaine, completed for social interaction, or omitted within a session. All points and bars represent the mean ± SEM. Lines represent main effect of Reinforcer (p < 0.05); Symbols represent significant (p < 0.05) post-hoc comparisons: $difference between cocaine, social, and omitted; *difference from the other reinforcer and omitted; %difference between social and omitted; #Difference from omitted trials only. n = 2–5 (2M/3F) for saline, n = 4–6 (2M/4F) for 0.1 mg/kg/inf cocaine, n = 3–5 (2M/3F) for 0.32 mg/kg/inf cocaine, and n = 6–7 (3M/4F) for 1.0 mg/kg/inf cocaine dose.
Figure 3.
Figure 3.
Effect of increasing social interaction duration on cocaine-vs-social choice. (A) Percent cocaine choice between 1.0 mg/kg/inf cocaine and 30-s or 60-s social interaction. Points represent individual subject means for the final 2 days of testing; bars represent group means. (B) number of trials completed for each reinforcer or omitted across testing days. Points and bars represent the daily mean ± SEM. Lines represent main effect of Reinforcer; #difference from omitted trials only (p < 0.05) (C, D) Individual subject behavioral allocation on the final day of testing between cocaine (red), social interaction (black), or omitted trials (white) when the alternative to cocaine was 30-s (C) or 60-s social interaction (D)
Figure 4.
Figure 4.
Effect of removing social interaction on cocaine-vs-social choice. (A) Percent cocaine choice between 0.32 mg/kg/inf cocaine and 30-s or 0-s social interaction. Points represent individual subject means for the final 2 days of testing; bars represent group means. (B) number of trials completed for each reinforcer or omitted across testing days. Points and bars represent the daily mean ± SEM. (C, D) Individual subject behavioral allocation on the final day of testing between cocaine (red), social interaction (black), or omitted trials (white) when the alternative to cocaine is 30-s (C) or 0-s social interaction (D)
Figure 5.
Figure 5.
Effect of eliminating non-contingent reinforcer presentation on cocaine-vs-social choice. (A) Percent cocaine choice between 1.0 mg/kg/inf cocaine and 30 s social interaction with and without non-contingent cocaine and social presentation during the pre-choice sampling period of each daily session. Points represent individual subject means for the final 2 days of testing; bars represent group means. (B) number of trials completed for each reinforcer or omitted across testing days. Points and bars represent the daily mean ± SEM. Bars represent main effect of Reinforcer; #difference from omitted trials only (p < 0.05) (C, D) Individual subject behavioral allocation on the final day of testing between cocaine (red), social interaction (black), or omitted trials (white) with (C) or without non-contingent reinforcer presentation (D)

Similar articles

Cited by

References

    1. Baldwin AN, Banks ML, Marsh SA, Townsend EA, Venniro M, Shaham Y, Negus SS, 2022. Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats. Psychopharmacology (Berl) 239, 561–572. 10.1007/s00213-021-06048-7 - DOI - PMC - PubMed
    1. Banks ML, Negus SS, 2017. Insights from preclinical choice models on treating drug addiction. Trends in Pharmacological Sciences 38(2), 181–194. 10.1016/j.tips.2016.11.002 - DOI - PMC - PubMed
    1. Banks ML, Negus SS, 2012. Preclinical determinants of drug choice under concurrent schedules of drug self-administration. Advances in Pharmacological Sciences 2012, 1–17. 10.1155/2012/281768 - DOI - PMC - PubMed
    1. Calcagnetti DJ, Schechter MD, 1992. Place Conditioning Reveals the Rewarding Aspect of Social Interaction in Juvenile Rats. Physiology & Behavior 51, 667–672. - PubMed
    1. Cantin L, Lenoir M, Augier E, Vanhille N, Dubreucq S, Serre F, Vouillac C, Ahmed SH, 2010. Cocaine is low on the value ladder of rats: Possible evidence for resilience to addiction. PLoS ONE 5, 1–14. 10.1371/journal.pone.0011592 - DOI - PMC - PubMed

Publication types